MedPath

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus

Phase 2
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Registration Number
NCT01071850
Lead Sponsor
Astellas Pharma Inc
Brief Summary

Evaluate the efficacy, safety, and tolerability of multiple doses of ASP1941 compared to placebo over 12 weeks of therapy in adult patients with type 2 diabetes mellitus.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
412
Inclusion Criteria
  • Subject has been diagnosed with type 2 diabetes
  • Subject has a HbA1c value between 6.8 and 9.5%
  • Subject has never, is not currently taking anti-diabetic medication OR is receiving a single anti- diabetic agent or low-doses two anti-diabetic medications and is willing to discontinue them during the study
  • Subject is on a stable diet and exercise program
  • Female subject is not pregnant and agrees to use an acceptable form of contraception throughout the duration of the study
Exclusion Criteria
  • Subject has type 1 diabetes mellitus
  • Subject is using insulin therapy
  • Subject has a serum creatinine higher than upper limit of normal
  • Subject has an ALT and/or AST value higher than 3 times upper limit of normal or a total bilirubin value more than 2 times upper limit of normal
  • Subject has persistent, uncontrolled severe hypertension as indicated by a

systolic blood pressure >180 mmHg or a diastolic blood pressure of

>110mmHg

  • Subject has had significant cardiovascular disease such as myocardial infarction or a vascular intervention (e.g., angioplasty or stent) in the last 3 months
  • Subject is known to have hepatitis or be a carrier of hepatitis B surface

antigen, hepatitis C virus antibody or is known positive for HIV1 and/or

HIV2

  • Subject has a history of lactic acidosis
  • Subject has a history of drug and alcohol abuse/dependency within last 12

months

  • Subject has had a malignancy in the last 5 years, except for successfully

treated basal or squamous cell carcinoma of the skin or of the cervix

  • Subject has a symptomatic urinary tract infection or genital infection
  • Female subject is lactating
  • Subject has an unstable medical or psychiatric illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ASP1941 lowest doseipragliflozinoral tablet
ASP1941 low doseipragliflozinoral tablet
ASP1941 high doseipragliflozinoral tablet
PlaceboPlacebooral tablet
ASP1941 highest doseipragliflozinoral tablet
MetforminMetforminoral tablet
Primary Outcome Measures
NameTimeMethod
Mean change from baseline in Hemoglobin A1c (HbA1c)12 weeks
Secondary Outcome Measures
NameTimeMethod
Proportion of subjects achieving target goal of HbA1c <7.0%12 weeks
Proportion of subjects achieving target goal of HbA1c <6.5%12 weeks
Mean change from baseline in fasting plasma glucose (FPG)12 weeks

Trial Locations

Locations (59)

CSRA Partners in Health, Inc.

🇺🇸

Augusta, Georgia, United States

Atlanta Vascular Research Foundation, Atlanta Cardiology & Primary Care P.C.

🇺🇸

Tucker, Georgia, United States

Bride, Bharti Hospital

🇮🇳

Karnal, India

Diacon Hospital

🇮🇳

Bangalore, India

Cedar Crosse Research Center

🇺🇸

Chicago, Illinois, United States

Winston Technology Research, LLC

🇺🇸

Haleyville, Alabama, United States

Desert Clinical Research

🇺🇸

Mesa, Arizona, United States

Paul W. Davis, MD, PA

🇺🇸

Pine Bluff, Arkansas, United States

Clinical Innovations, Inc.

🇺🇸

Costa Mesa, California, United States

Expresscare Clinical Research

🇺🇸

Colorado Springs, Colorado, United States

Torrance Clinical Research

🇺🇸

Lomita, California, United States

Clinical Therapeutics Corp.

🇺🇸

Coral Gables, Florida, United States

Del Rosario Medical Clinic, Inc

🇺🇸

Huntington Park, California, United States

PAB Clinical Research

🇺🇸

Brandon, Florida, United States

A.G.A Clinical Trials DBA Neostart Group

🇺🇸

Hialeah, Florida, United States

Suncoast Clinical Research

🇺🇸

New Port Richey, Florida, United States

APEX Medical Research, AMR, Inc

🇺🇸

Chicago, Illinois, United States

MediSphere Medical Research

🇺🇸

Evansville, Indiana, United States

Bay West Endocrinology

🇺🇸

Towson, Maryland, United States

Prism Research

🇺🇸

Saint Paul, Minnesota, United States

PMG Research of Salisbury, LLC

🇺🇸

Salisbury, North Carolina, United States

PMG Research of Charlotte, LLC

🇺🇸

Charlotte, North Carolina, United States

Integris Family Care

🇺🇸

Yukon, Oklahoma, United States

Willamette Valley Clinical Studies

🇺🇸

Eugene, Oregon, United States

Primecare of Southeastern Ohio, Inc.

🇺🇸

Zanesville, Ohio, United States

PMG Research of Bristol, LLC

🇺🇸

Bristol, Tennessee, United States

Fleetwood Clinical Research

🇺🇸

Fleetwood, Pennsylvania, United States

Southeastern Research Associates, Inc.

🇺🇸

Taylors, South Carolina, United States

Holston Medical Group

🇺🇸

Kingsport, Tennessee, United States

Southwind Medical Specialist

🇺🇸

Memphis, Tennessee, United States

Corpus Christi Family Wellness Center

🇺🇸

Corpus Christi, Texas, United States

Punzi Medical Center

🇺🇸

Carrollton, Texas, United States

Hormone Care and Research Centre

🇮🇳

Ghaziabad, India

Fundacion de Caribe para le Investigacion Biomedica

🇨🇴

Barranquilla, Colombia

School of Medicine University of Rosario

🇨🇴

Bogota, Colombia

Centro de Reumatologia y ortopedia

🇨🇴

Barranquilla, Colombia

Aspen Clinical Research

🇺🇸

Orem, Utah, United States

BIOMELAB

🇨🇴

Barranquilla, Colombia

Dexa Diad Servicios Medicos

🇨🇴

Bogota, Colombia

Fundacion Cardiovascular de Columbia

🇨🇴

Floridablanca Santander, Colombia

TOTALL Diabetes Hormone Institute Pvt.Ltd.

🇮🇳

Indore, India

S R Kalla Memorial Gastro & General Hospital

🇮🇳

Jaipur, India

Amrita Institute of Medical Sciences and Research Centre, AIMS

🇮🇳

Kerala, India

Unidad Metabólica y Cardiovascular, SC.

🇲🇽

Cuernavaca, Mexico

Instituto Jaliscience de Investigacion Clinica

🇲🇽

Guadalajara, Mexico

Torre Medica Providencia

🇲🇽

Guadalajara, Mexico

Medical Care and Research

🇲🇽

Merida, Mexico

CEDIME, Instituto Vascular

🇲🇽

Merida, Mexico

Cebu Doctors' University Hospital

🇵🇭

Cebu, Philippines

Hospital Universitario Dr. Eleuterio Gonzalez

🇲🇽

Monterrey, Mexico

St. Paul's Hospital

🇵🇭

Iloilo City, Philippines

Amang Rodriguez Memorial Medical Center

🇵🇭

Marikina City, Philippines

San Juan De Dios Hospital

🇵🇭

Pasay City, Philippines

Parkway Medical Center

🇺🇸

Birmingham, Alabama, United States

Central Phoenix Medical Clinic

🇺🇸

Phoenix, Arizona, United States

San Diego Managed Care Group Clinical Research

🇺🇸

San Diego, California, United States

Rapid Medical Research

🇺🇸

Cleveland, Ohio, United States

Excel Clinical Research, LLC

🇺🇸

Houston, Texas, United States

Cetero Research

🇺🇸

San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath